Welcome: Guest

log in
Title Date Price Relevance
Global Generics
Product Code: DAT00873
Sep 2008 £180.00100 %
Generics: Global Industry Guide
Product Code: DAT04475
Oct 2007 £575.00100 %
Global Generics Industry Report
Product Code: CYG00020
Sep 2006 £550.00100 %
Partnering in the Global Generics Industry 2008: A guide to companies
Product Code: ESP00549
Jul 2008 £595.0078 %
Global Pharmaceutical Market Forecast to 2012
Product Code: RCS00492
Oct 2008 £1,210.0021 %
Dr. Reddy's Market Outlook, Forecasts and Analysis to 2012
Product Code: VIS00048
Apr 2007 £1,499.0021 %
The Global Antivirals Market
R&D Pipelines, Market Analysis and Competitive Landscape
Product Code: ARR00001
May 2007 £1,685.0021 %
Analyzing the Global Pharmaceutical Industry
Product Code: ARU00233
May 2007 £675.0021 %
Pricing & Reimbursement in Asia-Pacific
Product Code: SCR00022
Jan 2006 £1,095.0021 %
The Global Antibacterials Market
R&D Pipelines, Market Analysis and Competitive Landscape
Product Code: ARR00021
Aug 2007 £1,685.0021 %
World Generic Market Report 2008
Product Code: ESP00272
Dec 2007 £595.0021 %
Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry
Product Code: ARU02204
Jan 2008 £440.0021 %
Consolidation in the Generic Pharmaceutical Industry
An Evolving Landscape
Product Code: URC00023
Sep 2007 £1,250.0021 %
Booming Pharma Sector in India
Product Code: RCS00464
Aug 2008 £740.0021 %
A Guide to Drug Pricing and Reimbursement
Product Code: KAL00099
Aug 2007 £1,615.0021 %
The Top 10 Generic Pharmaceutical Companies
Positioning, Performance and SWOT Analyses
Product Code: RBI00248
Jun 2008 £1,995.0021 %
Herbal Supplements, Prescription Drugs, Rx-to-OTC Products
A Comparison
Product Code: BCC00041
Sep 2006 £3,265.0021 %
Indian Bulk Drugs
Product Code: CYG00072
Jul 2008 £600.0021 %
Generic Competition to 2009
The impact of patent expiries on sales of major drugs
Product Code: URC00012
Oct 2005 £795.0021 %
Future Growth Opportunities in Generics
The impact of consolidation on market and competitive dynamics
Product Code: RBI00115
Nov 2006 £1,495.0021 %
Mylan: PharmaVitae Generics Profile
Product Code: DAT03302
Nov 2007 £2,005.0021 %
Commercial Insight: Antibacterials
Growth in resistance rates drives niche indications
Product Code: DAT03925
Dec 2006 £8,000.0021 %
Generic Competition, 2007 to 2011
The impact of patent expiries on sales of major drugs
Product Code: URC00019
Feb 2007 £1,375.0021 %
United States Pharmaceuticals and Healthcare Report Q4 2008
Product Code: BMI02909
Nov 2008 £250.0021 %
Global Bulk Drugs Industry Report
Product Code: CYG00012
Aug 2006 £550.0021 %